Fairmount Funds Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-381,939
| Closed | -$8.07M | – | 22 |
|
|
2023
Q2 | $8.07M | Sell |
381,939
-2,745,490
| -88% | -$58M | 1.14% | 16 |
|
|
2023
Q1 | $62.8M | Buy |
3,127,429
+251,903
| +9% | +$5.06M | 10.8% | 3 |
|
|
2022
Q4 | $75.1M | Buy |
2,875,526
+196,544
| +7% | +$5.14M | 11.92% | 3 |
|
|
2022
Q3 | $27.4M | Buy |
2,678,982
+1,752,380
| +189% | +$17.9M | 4.81% | 9 |
|
|
2022
Q2 | $3.88M | Hold |
926,602
| – | – | 0.89% | 24 |
|
|
2022
Q1 | $4.62M | Hold |
926,602
| – | – | 1.09% | 20 |
|
|
2021
Q4 | $6.23M | Hold |
926,602
| – | – | 2.05% | 18 |
|
|
2021
Q3 | $5.08M | Buy |
926,602
+842,658
| +1,004% | +$4.62M | 1.85% | 20 |
|
|
2021
Q2 | $549K | Hold |
83,944
| – | – | 0.23% | 19 |
|
|
2021
Q1 | $702K | Sell |
83,944
-16,056
| -16% | -$134K | 0.3% | 18 |
|
|
2020
Q4 | $700K | Hold |
100,000
| – | – | 0.25% | 17 |
|
|
2020
Q3 | $624K | Buy |
+100,000
| New | +$624K | 0.26% | 17 |
|